α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease

Table 2 α2-Heremans-schmid glycoprotein levels (g/L) with respect to disease characteristics

	IBD	UC	CD	P value
Extent (UC)
Proctitis	-	0.35 ± 0.1	-	> 0.05
Left-sided colitis	-	0.34 ± 0.12	-
Pancolitis	-	0.35 ± 0.10	-
Location (CD)
Upper GI	-	-	0.29 ± 0.09	> 0.05
Ileum	-	-	0.32 ± 0.08
Colon	-	-	0.31 ± 0.09
Ileocolon	-	-	0.29 ± 0.07
Behavior (CD)
NS/NP (a)	-	-	0.33 ± 0.07	a vs b: < 0.01
Stricturing (b)	-	-	0.26 ± 0.07	a vs c: < 0.001
Penetrating (c)	-	-	0.26 ± 0.06	b vs c: > 0.05
Extraintestinal manifestations
None	0.33 ± 0.01	0.33 ± 0.09	0.33 ± 0.07	> 0.05
≥ 1	0.32 ± 0.01	0.36 ± 0.1	0.30 ± 0.08

IBD: Inflammatory bowel disease; UC: Ulcerative colitis; CD: Crohn’s disease; GI: Gastrointestinal; NS/NP: Non stricturing/Non penetrating.